BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris™ Infusion System

FRANKLIN LAKES, N.J., July 24, 2023 /PRNewswire/ -- BD Chairman, CEO and President Tom Polen issued the following message regarding the U.S. Food and Drug Administration 510 clearance for the...

Related Keywords

,Tom Polen ,Troy Kirkpatrick ,Francesca Demartino ,Linkedin ,Drug Administration ,President Tom Polen ,Infusion System ,Im Tom Polen ,Alaris System ,Markets ,